References
- Fokkens WJ, Lund VJ, Hopkins C, Hellings P, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J, Alobid I, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhin. 2020;58(1):1. doi:10.4193/Rhin20.401.
- Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract. 2021;9(3):1133–1141. doi:10.1016/j.jaip.2020.09.063.
- Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;14:127–134. doi:10.2147/JAA.S290424.
- Hulse K, Stevens W, Tan B, Schleimer R. Pathogenesis of nasal polyposis. Clin Exp Allergy. 2015;45(2):328–346. doi:10.1111/cea.12472.
- Kim DW, Cho SH. Emerging endotypes of chronic rhinosinusitis and its application to precision medicine. Allergy Asthma Immunol Res. 2017;9(4):299–306. doi:10.4168/aair.2017.9.4.299.
- Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy. 2022;77(3):812–826. doi:10.1111/all.15074.
- Yılmaz İ. Type 2 chronic rhinosinusitis with nasal polyps: from phenotype to endotype. J Allergy Clin Immunol Pract. 2021;9(1):600–601. doi:10.1016/j.jaip.2020.11.009.
- Blaiss MS. Chronic rhinosinusitis with nasal polyps management in the age of biologics. Allergy Asthma Proc. 2020;41(6):413–419. doi:10.2500/aap.2020.41.200069.
- Sireci F, Speciale R, Gallina S, Sorrentino R, Canevari F. Clarithromycin in the management of chronic rhinosinusitis: preliminary results of a possible its new use. Indian J Otolaryngol Head Neck Surg. 2018;70(1):87–91. doi:10.1007/s12070-017-1153-y.
- Lees KA, Orlandi RR, Oakley G, Alt JA. The role of macrolides and doxycycline in chronic rhinosinusitis. Immunol Allergy Clin North Am. 2020;40(2):303–315. doi:10.1016/j.iac.2019.12.005.
- Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, Hens G, Hellings P, Ebbens FA, Fokkens W, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069–1076. e4. doi:10.1016/j.jaci.2010.02.020.
- Cakir Cetin A, Kumus O, Keskinoglu P, Sutay S, Ecevit MC. Turkish validation of the Sino-Nasal Outcome Test-22. Clin Otolaryngol. 2019;44(4):557–564. doi:10.1111/coa.13332.
- Parasher AK, Kidwai SM, Konuthula N, Goljo E, Pan S, Saini AT, Del Signore A, Iloreta AM, Govindaraj S, Malkin BD, et al. The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps. Am J Otolaryngol. 2019;40(4):467–472. doi:10.1016/j.amjoto.2019.03.004.
- Pinto Bezerra Soter AC, Bezerra TF, Pezato R, Teles Abdo TR, Pilan RM, Pinna FR, Gevaert P, van Zele T, Bachert C, Voegels RL, et al. Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps. Rhinology. 2017;55(2):175–180. doi:10.4193/Rhino15.291.
- Lux CA, Wagner Mackenzie B, Johnston J, Zoing M, Biswas K, Taylor MW, Douglas RG. Antibiotic treatment for chronic rhinosinusitis: prescription patterns and associations with patient outcome and the sinus microbiota. Front Microbiol. 2020;11:595555. doi:10.3389/fmicb.2020.595555.
- Smith SS, Kim R, Douglas R. Is there a role for antibiotics in the treatment of chronic rhinosinusitis? J Allergy Clin Immunol. 2022;149(5):1504–1512. doi:10.1016/j.jaci.2022.02.004.